AstraZeneca (Japan)
About
In recent decades, authors affiliated with AstraZeneca (Japan) have published 401 papers, which have received a total of 20.6k indexed citations.
Scholars at this organization have produced 197 papers in Pulmonary and Respiratory Medicine, 147 papers in Oncology and 59 papers in Physiology on the topics of Lung Cancer Treatments and Mutations (80 papers), Asthma and respiratory diseases (56 papers) and Cancer Immunotherapy and Biomarkers (44 papers). Their work is cited by papers focused on Pulmonary and Respiratory Medicine (12.0k citations), Oncology (10.9k citations) and Molecular Biology (5.1k citations). Authors at AstraZeneca (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Nature, New England Journal of Medicine and Journal of Clinical Oncology. Some of AstraZeneca (Japan)'s most productive authors include Toshitaka Yajima, Nobuya Hayashi, Y. Itoh, Isamu Okamoto and Haiyi Jiang.
In The Last Decade
Fields of papers published by authors at AstraZeneca (Japan)
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
This network shows the specialization of papers affiliated with AstraZeneca (Japan) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.
Countries citing scholars working at AstraZeneca (Japan)
Since SpecializationCitations
This map shows the geographic impact of research produced by authors working at AstraZeneca (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (Japan) more than expected).
Explore institutions with similar magnitude of impact
Breakdown of academic impact, for scholars at HudsonAlpha Institute for Biotechnology Breakdown of academic impact, for scholars at Centre de Microbiologie du Sol et de l'Environnement Breakdown of academic impact, for scholars at March of Dimes Breakdown of academic impact, for scholars at Cooperative Institute for Climate and Satellites Breakdown of academic impact, for scholars at NIHR Wellcome Trust Southampton Clinical Research Facility Breakdown of academic impact, for scholars at Sunderby sjukhus Breakdown of academic impact, for scholars at International Breast Cancer Study Group Breakdown of academic impact, for scholars at Boehringer Ingelheim (United Kingdom)